Ligand validation:2VRL

MBN: TOLUENE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VRL_MBN_A_601	51%	84%	0.113	0.867	0.53	0.25	-	-	0	0	100%	1
2VRL_MBN_B_601	11%	73%	0.196	0.712	0.62	0.42	-	-	0	0	100%	1
5TDS_MBN_A_504	99%	91%	0.053	0.984	0.27	0.29	-	-	0	0	100%	1
4W53_MBN_A_200	92%	72%	0.092	0.981	0.23	0.84	-	-	2	0	100%	0.8
5TDT_MBN_D_502	91%	79%	0.08	0.966	0.5	0.36	-	-	1	0	100%	1
7L39_MBN_A_203	90%	88%	0.101	0.984	0.27	0.39	-	-	0	0	100%	0.55
2DN1_MBN_A_1001	82%	0%	0.106	0.962	7.88	6.7	5	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.